Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors

Biology of Blood and Marrow Transplantation

Volumn 22, Issue 2, 2016, Pages 359-370

  Young, Jo Anne H ^a   Logan, Brent R ^b   Wu, Juan ^c   Wingard, John R ^d   Weisdorf, Daniel J ^a   Mudrick, Cathryn ^c   Knust, Kristin ^c   Horowitz, Mary M ^b   Confer, Dennis L ^e   Dubberke, Erik R ^f   Pergam, Steven A ^g   Marty, Francisco M ^h   Strasfeld, Lynne M ⁱ   Brown, Janice M ^j   Langston, Amelia A ^k   Schuster, Mindy G ^l   Kaul, Daniel R ^m   Martin, Stanley I ⁿ   Anasetti, Claudio ^o  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c EMMES CORPORATION   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e Washington University School of Medicine ^*  (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g USA   (United States)

^h DANA FARBER CANCER INSTITUTE   (United States)

ⁱ OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^j STANFORD UNIVERSITY   (United States)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF PENNSYLVANIA   (United States)

^m UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

ⁿ OHIO STATE UNIVERSITY   (United States)

^o H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

more..

Author keywords

Aspergillosis; Bacteremia; Cytomegalovirus; Infection; Pre engraftment; Unrelated donor transplantation

Indexed keywords

ADULT; AGED; ARTICLE; ASPERGILLOSIS; BACTEREMIA; BACTERIAL INFECTION; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; ENGRAFTMENT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; INFECTION; INFECTION RATE; INFECTION RISK; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOSIS; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNRELATED DONORS; VIRUS INFECTION; ADVERSE EFFECTS; MIDDLE AGED; PROCEDURES; VIROLOGY;

ADULT; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; INFECTION; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; UNRELATED DONORS;

EID: 84958602733     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2015.09.013     Document Type: Article

References (27)

1. Anasetti C., Logan B.R., Lee S.J., et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med 2012, 367:1487-1496.
2. Holtick U., Albrecht M., Chemnitz J.M., et al. Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults-a systematic review and meta-analysis. Crit Rev Oncol Hematol 2015, 94:179-188.
3. Holtick U., Albrecht M., Chemnitz J.M., et al. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults. Cochrane Database Syst Rev 2014, 4:CD010189.
4. Stamatovic D., Balint B., Tukic L., et al. Impact of stem cell source on allogeneic stem cell transplantation outcome in hematological malignancies. Vojnosanit Pregl 2011, 68:1026-1032.
5. Korbling M. Peripheral blood stem cells: a novel source for allogeneic transplantation. Oncologist 1997, 2:104-113.
6. Appelbaum F.R. Choosing the source of stem cells for allogeneic transplantation: no longer a peripheral issue. Blood 1999, 94:381-383.
7. Campregher P.V., Hamerschlak N., Colturato V.A., et al. Survival and graft-versus-host disease in patients receiving peripheral stem cell compared to bone marrow transplantation from HLA-matched related donor: retrospective analysis of 334 consecutive patients. Eur J Haematol 2015, [Epub ahead of print]. 10.1111/ejh.12508.
8. Serody J.S., Sparks S.D., Lin Y., et al. Comparison of granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood progenitor cells and G-CSF-stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation. Biol Blood Marrow Transplant 2000, 6:434-440.
9. Champlin R.E., Schmitz N., Horowitz M.M., et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood 2000, 95:3702-3709.
10. Barge R.M., Brouwer R.E., Beersma M.F., et al. Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome. Bone Marrow Transplant 2001, 27:1053-1058.
11. Tomblyn M., Chiller T., Einsele H., et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009, 15:1143-1238.
12. Sherertz R.J., Belani A., Kramer B.S., et al. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. Am J Med 1987, 83:709-718.
13. Freifeld A.G., Bow E.J., Sepkowitz K.A., et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 2011, 52:e56-e93.
14. Pollack M., Heugel J., Xie H., et al. An international comparison of current strategies to prevent herpesvirus and fungal infections in hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 2011, 17:664-673.
15. Tuan I.Z., Dennison D., Weisdorf D.J. Pneumocystis carinii pneumonitis following bone marrow transplantation. Bone Marrow Transplant 1992, 10:267-272.
16. Boeckh M., Boivin G. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin Microbiol Rev 1998, 11:533-554.
17. van Burik J.-A.H., Carter S.L., Freifeld A.G., et al. Higher-risk of cytomegalovirus and aspergillus infections in recipients of T cell depleted unrelated bone marrow: Analysis of infectious complications in patients treated with T cell depletion versus immune suppressive therapy to prevent graft-versus-host disease. Biol Blood Marrow Transplant 2007, 13:1487-1498.
18. Copelan E., Casper J.T., Carter S.L., et al. A scheme for defining cause of death and its application in the T cell depletion trial. Biol Blood Marrow Transplant 2007, 13:1469-1476.
19. Kurtzberg J., Prasad V.K., Carter S.L., et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 2008, 112:4318-4327.
20. Tomblyn M., Young J.A., Haagenson M.D., et al. Decreased infections in recipients of unrelated donor hematopoietic cell transplantation from donors with an activating KIR genotype. Biol Blood Marrow Transplant 2010, 16:1155-1161.
21. Barker J.N., Hough R.E., van Burik J.A., et al. Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. Biol Blood Marrow Transplant 2005, 11:362-370.
22. Bachanova V., Brunstein C.G., Burns L.J., et al. Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma. Bone Marrow Transplant 2009, 43:237-244.
23. Lin D., Wei L., Yang I., Ying Z. Semiparametric regression for the mean and rate functions of recurrent events. J Royal Statist Soc 2000, 62:711-730.
24. Boeckh M., Gooley T.A., Myerson D., et al. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood 1996, 88:4063-4071.
25. Qayed M., Khurana M., Hilinski J., et al. Risk for CMV reactivation in children undergoing allogeneic hematopoietic stem cell transplantation. Pediatr Blood Cancer 2014, [Epub ahead of print]. 10.1002/pbc.25237.
26. Walker C.M., van Burik J.A., De For T.E., Weisdorf D.J. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources. Biol Blood Marrow Transplant 2007, 13:1106-1115.
27. Wald A., Leisenring W., van Burik J.A., Bowden R.A. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997, 175:1459-1466.